TABLE 2.
Subscale and total scores at the pre-ILI and 2 weeks post-ILI visits
| Time point |
|||||
|---|---|---|---|---|---|
| Possible score range |
Pre-ILI | 2 Weeks | p | ||
| Scores, Median (95 % CI) |
SWB | 0-28 | 25.335 (21.92, 26.55) |
25 (22.17, 26.4) |
0.078 |
| EWB | 0-24 | 22 (18.53, 22.58) |
20 (18.6, 22.27) |
0.797 | |
| PWB | 0-28 | 26 (22.45, 27.33) |
27 (21.85, 26.82) |
0.555 | |
| FWB | 0-28 | 24 (19.04, 25.64) |
24 (20.47, 25.13) |
0.57 | |
| MS | 0-64 | 51 (44, 56.51) |
57.5 (46.28, 58.85) |
0.296 | |
| MSS | 0-32 | 26.5 (19.58, 27.28) |
28.5 (19.08, 28.79) |
0.484 | |
| FACTG | 0-108 | 95 (83.79, 100.28) |
97 (85.57, 98.14) |
0.625 | |
| TOI | 0-120 | 98.335 (89.44, 108.73) |
104 (89.17, 109.36) |
0.329 | |
| FACTM | 0-172 | 140.5 (131.45, 156.31) |
149 (131.55, 156.43) |
0.169 | |
Higher scores indicate higher health-related quality of life. SWB social and family well-being, EWB emotional well-being, PWB physical well-being, FWB functional well-being, MS melanoma subscale, MSS melanoma surgery subscale, FACT-G Functional Assessment of Cancer Therapy-General, TOI trial outcome index, FACT-M Functional Assessment of Cancer Therapy-Melanoma